Effects of MRSA Bactericidal Gel To Promote Healing and Eliminate MRSA in cSSTI Vancogel(TM)

Description

Based on personal experience and the literature it is reasonable expectation that Vancomycin is a viable treatment in a direct contact form to eliminate MRSA from open wounds in order to heal the wounds by conventional means. The key question in my research has been to measure the effectiveness of my Vancomycin Gel by culturing the wound, applying the Gel in a controlled manner and then culturing the wound after one week. The end point to achieve in the process, is a clinical response of accelerated healing and negative culture report. Another question to solve is the duration of potency and stability of the Vancomycin gel over time.

Conditions

Bacterial Infections, Wounds

Study Overview

Study Details

Study overview

Based on personal experience and the literature it is reasonable expectation that Vancomycin is a viable treatment in a direct contact form to eliminate MRSA from open wounds in order to heal the wounds by conventional means. The key question in my research has been to measure the effectiveness of my Vancomycin Gel by culturing the wound, applying the Gel in a controlled manner and then culturing the wound after one week. The end point to achieve in the process, is a clinical response of accelerated healing and negative culture report. Another question to solve is the duration of potency and stability of the Vancomycin gel over time.

Topical MRSA Bactericidal Gel to Eliminate MRSA and Promote Accelerated Healing of cSSTI of Open Wounds

Effects of MRSA Bactericidal Gel To Promote Healing and Eliminate MRSA in cSSTI Vancogel(TM)

Condition
Bacterial Infections
Intervention / Treatment

-

Contacts and Locations

Jupiter

Robert S Berman MD /661 Maplewood Drive #21, Jupiter, Florida, United States, 33458

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * MRSA infected open wounds
  • * Acute and chronic wounds
  • * Type of wounds: venous stasis,diabetic, pressure, post surgical, post traumatic, and spontaneous
  • * Infection criteria: Include a positive culture for MRSA
  • * Location of ulcers: any place on the body
  • * Diagnosis of MRSA: Based on tissue cultures of MRSA
  • * Willing and reliable patients
  • * Study to include only one ulceration no more than 50 square centimeters
  • * The study to include stages two and three ulcerations
  • * Non-compliant patients
  • * Patient must accept all issues in consent form
  • * Non compliance to include failed appointments
  • * Wounds greater than 50sq. cm
  • * No wounds deeper than soft tissue
  • * Ischemic or vascular disease, dermatitis, immune deficiency,or psoriasis
  • * Allergy to Vancomycin
  • * Post irradiation ulceration
  • * Bleeding disorders
  • * Skin allergies to adhesives and tape
  • * Ulcers related to cancers
  • * Multiple wounds
  • * Stage 4 ulcerations
  • * Patients in any other trial
  • * Patients with any other conditions which, in the opinion of the investigator/doctor, would preclude participation in the study.

Ages Eligible for Study

18 Years to

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

Yes

Collaborators and Investigators

Robert S Berman MD,

Robert S Berman, MD, PRINCIPAL_INVESTIGATOR,

Study Record Dates

2024-12-15